awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47777833-0E3AEF60-675A-4B2A-BA98-F25A930B7B3F
Q47777833-0E3AEF60-675A-4B2A-BA98-F25A930B7B3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47777833-0E3AEF60-675A-4B2A-BA98-F25A930B7B3F
Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study.
P2860
Q47777833-0E3AEF60-675A-4B2A-BA98-F25A930B7B3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47777833-0E3AEF60-675A-4B2A-BA98-F25A930B7B3F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ac174602888b321f36c47eb03e170b3453588d0
P2860
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.